CHS Fiscal 2026 Net Income Nearly Doubles to $1.1B on Refining Margins
CHSCP is trading near its 52-week low of $25.38 (1.1% above the low) on light trading volume (0.2× avg).
Summary
CHS reported fiscal 2026 net income attributable to the company of $1.096 billion, nearly double last year's $597.9 million, as refining margins recovered, and guided fiscal 2027 capital spending up to about $850.8 million for new soybean processing and fertilizer joint venture projects.
Key Events · Earnings and Guidance · CHSCP
-
Fiscal 2026 Earnings Nearly Double
Net income attributable to CHS Inc. was $1,095.9 million on revenues of $39.23 billion, versus $597.9 million on $35.46 billion in fiscal 2025.
-
Energy Segment Drives the Swing
Energy income before income taxes rose to $554.6 million from a $19.0 million loss, as the Group 3 2:1:1 crack spread averaged $35.15 per barrel versus $19.91 a year earlier.
-
RIN Costs and SRE Benefit
D6 ethanol RINs rose 86% and D4 biodiesel RINs 82% year over year, partly offset by a $205.0 million small refinery exemption benefit recognized in fiscal 2026.
-
Fiscal 2027 Capex Steps Up Sharply
Management expects capital expenditures of approximately $850.8 million in fiscal 2027 versus $463.3 million in fiscal 2026, including the Evansville, Wisconsin soybean processing facility and OCP North America phosphate joint venture development costs.
Analysis · CHSCP · Trade & Services
Refining margins powered CHS's fiscal 2026 results: net income attributable to the cooperative jumped to $1.096 billion from $597.9 million a year earlier, driven almost entirely by the Energy segment, which swung from a $19.0 million loss to $554.6 million of income before taxes as crack spreads widened (Group 3 2:1:1 crack spread averaged $35.15/bbl versus $19.91) and the McPherson refinery returned to full operation after its fiscal 2025 turnaround. That gain came despite record-high renewable fuel credit costs — D6 ethanol RINs rose 86% and D4 biodiesel RINs 82% — partly offset by a $205.0 million small refinery exemption benefit. The offsetting story is capital intensity: management guides fiscal 2027 capital spending to roughly $850.8 million, nearly double fiscal 2026's $463.3 million, to fund a new Evansville, Wisconsin soybean processing plant and development costs on a proposed phosphate fertilizer joint venture with OCP North America. For preferred holders, the key facts are that all five preferred series dividends were paid in full ($168.7 million) and debt covenants were met, with roughly $168.7 million of preferred dividends expected again in fiscal 2027.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHSCP was trading at $25.65 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $313.5M. The 52-week trading range was $25.38 to $28.94. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.